Iress Ltd reports tomorrow: Will it surge higher?

Massive growth is expected from Iress Ltd (ASX:IRE) when it reports tomorrow.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Financial software and service provider Iress Ltd (ASX: IRE) is set to release its results for the 12 months to 31 December 2014 on February 25. Iress operates a number of dominant services to financial institutions and investors. These include:

  • Financial planning software XPLAN,
  • The highly regarded IRESS sharemarket platform, and
  • Class Super, a self-managed super fund monitoring and reporting platform.

2014: A year of expansion

IRESS made a number of important business decisions over the last 18 months that are expected to boost earnings per share by as much as 25% this year. IRESS purchased the Avelo group as well as Spotlight and Plantech in 2013, allowing the group to launch IRESS and XPLAN into the UK, and XPLAN into South Africa.

Iress has also launched the IRESS platform into Canada, while an expansion into Asia is underway but is less developed.

Earnings Expectations

Analysts are expecting a massive year of growth from Iress. Investors should expect:

  • Earnings per share growth of 18% from 37.4 cents to 44 cents
  • Net profit after tax of $70 million, up from $53 million last year
  • Dividend per share of 40 cents, up from 38 cents last year

In addition, investors should look for a positive outlook of low to mid single digit growth in the year ahead. It's also worth looking for positive commentary about the state of financial markets and the impact on broking volume, evidence of consolidation or growth in Australian market share, and positive signs from the UK, South African and Asian businesses.

Dividend Ambitions

Iress has typically been a company that pays out a large portion of free cash flow as dividends. Based on today's price of $11.00, Iress is rewarding investors with a dividend yield of 3.6%, franked at around 50%.

Motley Fool contributor Andrew Mudie does not own shares in any companies mentioned. You can find Andrew on Twitter @andrewmudie

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »